Stanley Black & Decker, Inc. vs BIO-TECHNE Corp — how do they compare? Stanley Black & Decker, Inc. trades at $103.91 (market cap $15.50B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Stanley Black & Decker, Inc. is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| SWK | TECH | |
|---|---|---|
Market Cap | $15.50B | $11.24B |
52-Week High | $103.89 | $72.29 |
52-Week Low | $62.12 | $43.31 |
Enterprise Value | $19.67B | $11.32B |
Dividend Yield | 3.27% | 0.44% |
Sector | — | Health |
Signals from Pluang's Aura AI — not financial advice
Stanley Black & Decker (SWK) trades at $103.89, up 2.82% today, showing strong momentum after recent earnings beats. The stock demonstrates improving fundamentals with Q2 2026 EPS of $1.57 beating estimates by 30%, while technical indicators show bullish moving averages but overbought RSI levels. Recent corporate developments include debt reduction of $1.7 billion and a dividend increase to $0.84 per share.
SWK presents a mixed outlook with strong operational improvements and margin expansion offset by valuation concerns. The stock trades above analyst consensus target of $93.67, suggesting limited near-term upside. Key opportunities include continued margin recovery and market share gains, while risks involve economic sensitivity and competitive pressures in the tools industry.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Trailing returns across standard periods
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →